In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

InDex Pharmaceuticals Holding AB

https://www.indexpharma.com/en/

Latest From InDex Pharmaceuticals Holding AB

Finance Watch: Neuron23 Adds $100m To Take First Drug Into The Clinic

Private Company Edition: Westlake Village BioPartners-founded Neuron23 will take the LRRK2 inhibitor NEU-723 for Parkinson’s disease into human testing before the end of 2022. Also, Celsius raised $83m in fresh VC cash and ITM added another €33m to its recent €25m equity financing.

StartUps and SMEs Financing

InDex To Fly Solo With Ulcerative Colitis Drug In US

Approval is unlikely before 2027 but Sweden’s InDex has done the maths and decided that it can launch cobitolimod across the Atlantic on its own with a staff of around 100.

Launches Gastrointestinal

Asia Deal Watch: I-Mab Partners With Sinopharm As It Readies First Regulatory Filing

I-Mab sets commercial plans with Sinopharm for felzartamab in multiple myeloma. Legochem and Antengene team up on antibody-drug conjugates, Luoxin licenses respiratory drug from Marinomed.

Deal Watch Business Strategies

InDex Gets Cash Boost For Phase III Ulcerative Colitis Drug

The Stockholm-based company is in a position to start the Phase III program for its ulcerative colitis candidate after raising over $64m in a rights issue.

Financing Gastrointestinal
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Digital Imaging
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
    • Pharmacogenetics-Pharmacogenomics
    • Drug Discovery Tools
      • ADMET
UsernamePublicRestriction

Register